Self-Emulsifying Drug Delivery Systems: An Alternative Approach to Improve Brain Bioavailability of Poorly Water-Soluble Drugs through Intranasal Administration

被引:19
作者
Meirinho, Sara [1 ,2 ]
Rodrigues, Marcio [1 ,2 ,3 ]
Santos, Adriana O. [1 ,2 ]
Falcao, Amilcar [4 ,5 ]
Alves, Gilberto [1 ,2 ]
机构
[1] Univ Beira Interior, CICS UBI Hlth Sci Res Ctr, Av Infante D Henrique, P-6200506 Covilha, Portugal
[2] Univ Beira Interior, Fac Hlth Sci, Av Infante D Henrique, P-6200506 Covilha, Portugal
[3] Polythecn Inst Guarda, CPIRN UDI IPG Ctr Potential & Innovat Nat Resourc, Res Unit Inland Dev, P-6300559 Guarda, Portugal
[4] Univ Coimbra, CIBIT ICNAS Coimbra Inst Biomed Imaging & Transla, Inst Nucl Sci Appl Hlth, Polo Ciencias Saude, P-3000548 Coimbra, Portugal
[5] Univ Coimbra, Fac Pharm, Lab Pharmacol, Polo Ciemcias Saude, P-3000548 Coimbra, Portugal
关键词
bioavailability; brain; intranasal; neurotherapeutics; self-emulsifying drug delivery systems; IN-VITRO; ORAL BIOAVAILABILITY; FORMULATION; PERMEABILITY; QUANTIFICATION; CARBAMAZEPINE; ENHANCEMENT; PERFORMANCE; EFFICACY; SMEDDS;
D O I
10.3390/pharmaceutics14071487
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Efforts in discovering new and effective neurotherapeutics are made daily, although most fail to reach clinical trials. The main reason is their poor bioavailability, related to poor aqueous solubility, limited permeability through biological membranes, and the hepatic first-pass metabolism. Nevertheless, crossing the blood-brain barrier is the major drawback associated with brain drug delivery. To overcome it, intranasal administration has become more attractive, in some cases even surpassing the oral route. The unique anatomical features of the nasal cavity allow partial direct drug delivery to the brain, circumventing the blood-brain barrier. Systemic absorption through the nasal cavity also avoids the hepatic first-pass metabolism, increasing the systemic bioavailability of highly metabolized entities. Nevertheless, most neurotherapeutics present physicochemical characteristics that require them to be formulated in lipidic nanosystems as self-emulsifying drug delivery systems (SEDDS). These are isotropic mixtures of oils, surfactants, and co-surfactants that, after aqueous dilution, generate micro or nanoemulsions loading high concentrations of lipophilic drugs. SEDDS should overcome drug precipitation in absorption sites, increase their permeation through absorptive membranes, and enhance the stability of labile drugs against enzymatic activity. Thus, combining the advantages of SEDDS and those of the intranasal route for brain delivery, an increase in drugs' brain targeting and bioavailability could be expected. This review deeply characterizes SEDDS as a lipidic nanosystem, gathering important information regarding the mechanisms associated with the intranasal delivery of drugs loaded in SEDDS. In the end, in vivo results after SEDDS intranasal or oral administration are discussed, globally revealing their efficacy in comparison with common solutions or suspensions.
引用
收藏
页数:28
相关论文
共 72 条
  • [1] The Potential Synergistic Activity of Zolmitriptan Combined in New Self-Nanoemulsifying Drug Delivery Systems: ATR-FTIR Real-Time Fast Dissolution Monitoring and Pharmacodynamic Assessment
    Abd El-Halim, Shady M.
    Mamdouh, Mohamed A.
    Eid, Sherif M.
    Ibrahim, Bassant M. M.
    Labib, Dina A. Aly
    Soliman, Sara M.
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 6395 - 6412
  • [2] Development, Characterization, and in-vivo Pharmacokinetic Study of Lamotrigine Solid Self-Nanoemulsifying Drug Delivery System
    Abdelmonem, Rehab
    Azer, Marian Sobhy
    Makky, Amna
    Zaghloul, Abdelazim
    El-Nabarawi, Mohamed
    Nada, Aly
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 4343 - 4362
  • [3] Self-emulsifying drug delivery system: Mucus permeation and innovative quantification technologies
    Abdulkarim, Muthanna
    Sharma, Peeyush Kumar
    Gumbleton, Mark
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2019, 142 : 62 - 74
  • [4] Role of self-emulsifying drug delivery systems in optimizing the oral delivery of hydrophilic macromolecules and reducing interindividual variability
    AboulFotouh, Khaled
    Allam, Ayat A.
    El-Badry, Mahmoud
    El-Sayed, Ahmed M.
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2018, 167 : 82 - 92
  • [5] Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
    Agrawal, Mukta
    Saraf, Shailendra
    Saraf, Swarnlata
    Dubey, Sunil K.
    Puri, Anu
    Gupta, Umesh
    Kesharwani, Prashant
    Ravichandiran, V
    Kumar, Pramod
    Naidu, V. G. M.
    Murty, Upadhyayula Suryanarayana
    Ajazuddin
    Alexander, Amit
    [J]. JOURNAL OF CONTROLLED RELEASE, 2020, 327 : 235 - 265
  • [6] Agu Remigius U., 2008, V7, P112
  • [7] Ahmad N, 2017, DRUG RES, V67, P564, DOI 10.1055/s-0043-109564
  • [8] Advances in Oral Drug Delivery
    Alqahtani, Mohammed S.
    Kazi, Mohsin
    Alsenaidy, Mohammad A.
    Ahmad, Muhammad Z.
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [9] Ammar HO., 2018, INT J PHARM SCI DEV, V4, P009
  • [10] [Anonymous], 2005, Neurological disorders affect millions globally: WHO report